Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489278 · ClinicalTrials.gov registry record
Clinical Procedures to Support Research in ALS
A clinical trial of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, sponsored by University of Miami.
- Recruiting
- Registry status
- 1,200
- Enrollment target
- 11
- Study locations
NCT03489278: Recruiting study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, sponsored by University of Miami.
NCT03489278 is a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 1,200 participants, above the 886-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (35% higher). The trial reports 11 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03489278, a study of Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 1,200 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.
Conditions Studied
Study Locations (11)
California
- University of California, Irvine - Irvine
- Stanford University - Palo Alto
- California Pacific Medical Center - San Francisco
North Carolina
- Duke University - Durham
- Wake Forest University - Winston-Salem
Florida
- University of Miami - Miami
Kansas
- University of Kansas Medical Center - Kansas City
Minnesota
- Hennepin County Medical Center - Minneapolis
New York
- Columbia University - New York
Oregon
- Providence Health & Services - Portland
Texas
- University of Texas San Antonio Health Science Center - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2018-02-15 |
| Est. Completion | 2027-06 |
What NCT03489278 shows while recruiting
NCT03489278 is an observational study that tracks outcomes without assigning an intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 886-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (35% higher).
The record links to 4 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT03489278 lists 11 locations in 8 states (California, North Carolina, Florida).
Frequently Asked Questions
What is clinical trial NCT03489278 about?
NCT03489278 is a clinical study titled "Clinical Procedures to Support Research in ALS". The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.
What is the current status of trial NCT03489278?
This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2018-02-15. Estimated completion is 2027-06.
What conditions does trial NCT03489278 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis, Progressive Muscular Atrophy, ALS-Frontotemporal Dementia.
Who is sponsoring clinical trial NCT03489278?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03489278 being conducted?
This trial has 11 study locations across California, Florida, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03489278's enrollment target sits among peer trials
1,200 11th of 102 higher than 92 of 102 other Amyotrophic Lateral Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI